Suzanne E.T. Comans

Suzanne E.T. Comans

Auto-generated profile, based on publicly available information

Suzanne E.T. Comans

Department of Laboratory Medicine, Laboratory of Medical Immunology, Radboud Community for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 February 2026 in Journal of Infection
Verified
Journal Article
Open access
LBLucille van Beek
Lucille van Beek
SCSuzanne E.T. Comans
Suzanne E.T. Comans
KTKoen Totté
Koen Totté
JFJaneri Fröberg
Janeri Fröberg
CJChrista E. van der Gaast-De Jongh
Christa E. van der Gaast-De Jongh
DDDimitri A. Diavatopoulos
Dimitri A. Diavatopoulos
Colonisation of the upper airways by Streptococcus pneumoniae is a prerequisite for disease development and shapes immune responses that vary between geographical settings. This first controlled human pneumococcal infection study in the Netherlands assessed colonisation, antibody responses, respiratory symptoms, and concurrent viral infections. Twenty healthy adults (19-47 years) were enrolled between May 2022 and February 2023 and inoculated intranasally with 160,000 colony forming units of S. pneumoniae serotype 6B (strain BHN418). Participants were monitored for 28 days to assess colonisation, respiratory viral infection and safety. Serum and nasal lining fluid were collected to measure IgA, IgM and IgG responses to serotype 6B polysaccharide (6B) and whole pneumococci. Eight of 20 participants (40%) became colonised. Colonised participants showed significant rises in serum and mucosal IgG and IgA to 6B, but not to pneumococci. Fifteen participants tested positive for at least one respiratory virus. Symptoms were generally mild but occurred more often in those with concurrent pneumococcal colonisation and viral infection. Colonisation rates were comparable to studies in other populations. Colonisation induced systemic and mucosal antibody responses, while viral co-infection increased symptom burden. This controlled infection study demonstrates feasibility and safety, and establishes a platform for vaccine evaluation and pneumococcal-viral interaction studies.

14 September 2026 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
SCSuzanne E.T. Comans
Suzanne E.T. Comans
JMJussi Mertsola
Jussi Mertsola
DDDimitri A. Diavatopoulos
Dimitri A. Diavatopoulos
HGHans de Graaf
Hans de Graaf
Was not provided for this article.